Cargando…
AKT1(low) quiescent cancer cells in ductal carcinoma in situ of the breast
Ductal carcinoma in situ (DCIS) of the breast precedes the development of invasive breast cancer and reflects the genomic changes and protein expression profile of invasive disease. AKT1(low) cancer cells (QCC) are a rare, drug-tolerant, epigenetically plastic, and quiescent cancer cell subset that...
Autores principales: | Kabraji, Sheheryar, Sole, Xaiver, Huang, Ying, Bango, Clyde, Sgroi, Dennis, Loda, Massimo, Ramaswamy, Sridhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428812/ https://www.ncbi.nlm.nih.gov/pubmed/30911675 http://dx.doi.org/10.1038/s41523-019-0105-y |
Ejemplares similares
-
AKT1(low) quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer
por: Kabraji, Sheheryar, et al.
Publicado: (2017) -
Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
por: Doebar, S. C., et al.
Publicado: (2018) -
THER-12. PRECLINICAL EVALUATION OF NERATINIB PLUS T-DM1 IN ORTHOTOPIC PDX MODELS OF HER2-POSITIVE BREAST CANCER BRAIN METASTASES
por: Ni, Jing, et al.
Publicado: (2019) -
Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012) -
Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)